Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Enhances the Collateral Blood Flow in the Ischemic Hindlimb

Yasukatsu Izumi, Yasukatsu Izumi, Takehiro Yamaguchi, Takanori Yamazaki, Naoto Yamashita, Yasuhiro Nakamura, Yasuhiro Nakamura, Masayuki Shiota, Masako Tanaka, Masako Tanaka, Soichi Sano, Mayuko Osada-oka, Mayuko Osada-oka, Kenei Shimada, Hideki Wanibuchi, Katsuyuki Miura, Minoru Yoshiyama, Hiroshi Iwao

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aim: Highly concentrated carbon dioxide (CO2) is thought to be useful for ischemic diseases. We investigated whether treatment with a few micrometers of CO2 molecules atomized via two fluidnozzles (CO2 mist) exerts an angiogenic effect in a mouse ischemic hindlimb model. Methods: Mice with unilateral hindlimb ischemia were divided into untreated (UT), 100% CO2 gas alone-treated (CG), mixed air (O2; 20%, N2; 80%) mist-treated (AM) and 100% CO2 mist-treated (CM) groups. The lower body of the mice was encased in a polyethylene bag filled with each gaseous agent using a gas mist generator for 10 minutes daily. Results: According to a laser Doppler analysis, the ischemic hindlimb blood flow was persistently higher after the seventh day of induction of ischemia in the CM group than in the UT group. The capillary density was also greater in the CM group on day 28 compared with that observed in the UT group. In addition, the parameters in the AM and CG groups were similar to those obtained in the UT group. The observed effects were abolished by the administration of an inhibitor of nitric oxide synthase (NOS). The vascular endothelial growth factor mRNA expression and protein levels and the phosphorylated endothelial NOS level were increased in the CM group compared with that observed in the UT group. A proteomic analysis using liquid chromatography-tandem mass spectrometry identified novel protein candidates regulated by CO2 mist. Conclusion: Percutaneous CO2 mist therapy may be useful for treating ischemia-induced angiogenesis.

Original languageEnglish
Pages (from-to)38-51
Number of pages14
JournalJournal of Atherosclerosis and Thrombosis
Volume22
Issue number1
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Fog
Hindlimb
Carbon Dioxide
Blood
Ischemia
Gases
Nitric Oxide Synthase Type III
Polyethylene
Tandem Mass Spectrometry
Nitric Oxide Synthase
Liquid Chromatography
Proteomics
Vascular Endothelial Growth Factor A
Proteins
Lasers
Air
Messenger RNA
Liquid chromatography
Mass spectrometry
Therapeutics

Keywords

  • Angiogenesis
  • Carbon dioxide mist
  • Ischemia
  • Mass spectrometry
  • Peripheral arterial disease

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine
  • Biochemistry, medical

Cite this

Izumi, Y., Izumi, Y., Yamaguchi, T., Yamazaki, T., Yamashita, N., Nakamura, Y., ... Iwao, H. (2015). Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Enhances the Collateral Blood Flow in the Ischemic Hindlimb. Journal of Atherosclerosis and Thrombosis, 22(1), 38-51.

Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Enhances the Collateral Blood Flow in the Ischemic Hindlimb. / Izumi, Yasukatsu; Izumi, Yasukatsu; Yamaguchi, Takehiro; Yamazaki, Takanori; Yamashita, Naoto; Nakamura, Yasuhiro; Nakamura, Yasuhiro; Shiota, Masayuki; Tanaka, Masako; Tanaka, Masako; Sano, Soichi; Osada-oka, Mayuko; Osada-oka, Mayuko; Shimada, Kenei; Wanibuchi, Hideki; Miura, Katsuyuki; Yoshiyama, Minoru; Iwao, Hiroshi.

In: Journal of Atherosclerosis and Thrombosis, Vol. 22, No. 1, 2015, p. 38-51.

Research output: Contribution to journalArticle

Izumi, Y, Izumi, Y, Yamaguchi, T, Yamazaki, T, Yamashita, N, Nakamura, Y, Nakamura, Y, Shiota, M, Tanaka, M, Tanaka, M, Sano, S, Osada-oka, M, Osada-oka, M, Shimada, K, Wanibuchi, H, Miura, K, Yoshiyama, M & Iwao, H 2015, 'Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Enhances the Collateral Blood Flow in the Ischemic Hindlimb', Journal of Atherosclerosis and Thrombosis, vol. 22, no. 1, pp. 38-51.
Izumi, Yasukatsu ; Izumi, Yasukatsu ; Yamaguchi, Takehiro ; Yamazaki, Takanori ; Yamashita, Naoto ; Nakamura, Yasuhiro ; Nakamura, Yasuhiro ; Shiota, Masayuki ; Tanaka, Masako ; Tanaka, Masako ; Sano, Soichi ; Osada-oka, Mayuko ; Osada-oka, Mayuko ; Shimada, Kenei ; Wanibuchi, Hideki ; Miura, Katsuyuki ; Yoshiyama, Minoru ; Iwao, Hiroshi. / Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Enhances the Collateral Blood Flow in the Ischemic Hindlimb. In: Journal of Atherosclerosis and Thrombosis. 2015 ; Vol. 22, No. 1. pp. 38-51.
@article{5ddec87fe14f4e768849bd6489521956,
title = "Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Enhances the Collateral Blood Flow in the Ischemic Hindlimb",
abstract = "Aim: Highly concentrated carbon dioxide (CO2) is thought to be useful for ischemic diseases. We investigated whether treatment with a few micrometers of CO2 molecules atomized via two fluidnozzles (CO2 mist) exerts an angiogenic effect in a mouse ischemic hindlimb model. Methods: Mice with unilateral hindlimb ischemia were divided into untreated (UT), 100{\%} CO2 gas alone-treated (CG), mixed air (O2; 20{\%}, N2; 80{\%}) mist-treated (AM) and 100{\%} CO2 mist-treated (CM) groups. The lower body of the mice was encased in a polyethylene bag filled with each gaseous agent using a gas mist generator for 10 minutes daily. Results: According to a laser Doppler analysis, the ischemic hindlimb blood flow was persistently higher after the seventh day of induction of ischemia in the CM group than in the UT group. The capillary density was also greater in the CM group on day 28 compared with that observed in the UT group. In addition, the parameters in the AM and CG groups were similar to those obtained in the UT group. The observed effects were abolished by the administration of an inhibitor of nitric oxide synthase (NOS). The vascular endothelial growth factor mRNA expression and protein levels and the phosphorylated endothelial NOS level were increased in the CM group compared with that observed in the UT group. A proteomic analysis using liquid chromatography-tandem mass spectrometry identified novel protein candidates regulated by CO2 mist. Conclusion: Percutaneous CO2 mist therapy may be useful for treating ischemia-induced angiogenesis.",
keywords = "Angiogenesis, Carbon dioxide mist, Ischemia, Mass spectrometry, Peripheral arterial disease",
author = "Yasukatsu Izumi and Yasukatsu Izumi and Takehiro Yamaguchi and Takanori Yamazaki and Naoto Yamashita and Yasuhiro Nakamura and Yasuhiro Nakamura and Masayuki Shiota and Masako Tanaka and Masako Tanaka and Soichi Sano and Mayuko Osada-oka and Mayuko Osada-oka and Kenei Shimada and Hideki Wanibuchi and Katsuyuki Miura and Minoru Yoshiyama and Hiroshi Iwao",
year = "2015",
language = "English",
volume = "22",
pages = "38--51",
journal = "Journal of Atherosclerosis and Thrombosis",
issn = "1340-3478",
publisher = "Japan Atherosclerosis Society",
number = "1",

}

TY - JOUR

T1 - Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Enhances the Collateral Blood Flow in the Ischemic Hindlimb

AU - Izumi, Yasukatsu

AU - Izumi, Yasukatsu

AU - Yamaguchi, Takehiro

AU - Yamazaki, Takanori

AU - Yamashita, Naoto

AU - Nakamura, Yasuhiro

AU - Nakamura, Yasuhiro

AU - Shiota, Masayuki

AU - Tanaka, Masako

AU - Tanaka, Masako

AU - Sano, Soichi

AU - Osada-oka, Mayuko

AU - Osada-oka, Mayuko

AU - Shimada, Kenei

AU - Wanibuchi, Hideki

AU - Miura, Katsuyuki

AU - Yoshiyama, Minoru

AU - Iwao, Hiroshi

PY - 2015

Y1 - 2015

N2 - Aim: Highly concentrated carbon dioxide (CO2) is thought to be useful for ischemic diseases. We investigated whether treatment with a few micrometers of CO2 molecules atomized via two fluidnozzles (CO2 mist) exerts an angiogenic effect in a mouse ischemic hindlimb model. Methods: Mice with unilateral hindlimb ischemia were divided into untreated (UT), 100% CO2 gas alone-treated (CG), mixed air (O2; 20%, N2; 80%) mist-treated (AM) and 100% CO2 mist-treated (CM) groups. The lower body of the mice was encased in a polyethylene bag filled with each gaseous agent using a gas mist generator for 10 minutes daily. Results: According to a laser Doppler analysis, the ischemic hindlimb blood flow was persistently higher after the seventh day of induction of ischemia in the CM group than in the UT group. The capillary density was also greater in the CM group on day 28 compared with that observed in the UT group. In addition, the parameters in the AM and CG groups were similar to those obtained in the UT group. The observed effects were abolished by the administration of an inhibitor of nitric oxide synthase (NOS). The vascular endothelial growth factor mRNA expression and protein levels and the phosphorylated endothelial NOS level were increased in the CM group compared with that observed in the UT group. A proteomic analysis using liquid chromatography-tandem mass spectrometry identified novel protein candidates regulated by CO2 mist. Conclusion: Percutaneous CO2 mist therapy may be useful for treating ischemia-induced angiogenesis.

AB - Aim: Highly concentrated carbon dioxide (CO2) is thought to be useful for ischemic diseases. We investigated whether treatment with a few micrometers of CO2 molecules atomized via two fluidnozzles (CO2 mist) exerts an angiogenic effect in a mouse ischemic hindlimb model. Methods: Mice with unilateral hindlimb ischemia were divided into untreated (UT), 100% CO2 gas alone-treated (CG), mixed air (O2; 20%, N2; 80%) mist-treated (AM) and 100% CO2 mist-treated (CM) groups. The lower body of the mice was encased in a polyethylene bag filled with each gaseous agent using a gas mist generator for 10 minutes daily. Results: According to a laser Doppler analysis, the ischemic hindlimb blood flow was persistently higher after the seventh day of induction of ischemia in the CM group than in the UT group. The capillary density was also greater in the CM group on day 28 compared with that observed in the UT group. In addition, the parameters in the AM and CG groups were similar to those obtained in the UT group. The observed effects were abolished by the administration of an inhibitor of nitric oxide synthase (NOS). The vascular endothelial growth factor mRNA expression and protein levels and the phosphorylated endothelial NOS level were increased in the CM group compared with that observed in the UT group. A proteomic analysis using liquid chromatography-tandem mass spectrometry identified novel protein candidates regulated by CO2 mist. Conclusion: Percutaneous CO2 mist therapy may be useful for treating ischemia-induced angiogenesis.

KW - Angiogenesis

KW - Carbon dioxide mist

KW - Ischemia

KW - Mass spectrometry

KW - Peripheral arterial disease

UR - http://www.scopus.com/inward/record.url?scp=84921853940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921853940&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 38

EP - 51

JO - Journal of Atherosclerosis and Thrombosis

JF - Journal of Atherosclerosis and Thrombosis

SN - 1340-3478

IS - 1

ER -